ADC Therapeutics SA (ADCT)
NYSE: ADCT · Real-Time Price · USD
3.250
-0.110 (-3.27%)
At close: May 15, 2026, 4:00 PM EDT
3.300
+0.050 (1.54%)
After-hours: May 15, 2026, 7:00 PM EDT
ADC Therapeutics Employees
As of December 31, 2025, ADC Therapeutics had 193 total employees, including 188 full-time and 5 part-time employees. The number of employees decreased by 72 or -27.17% compared to the previous year.
Employees
193
Change (1Y)
-72
Growth (1Y)
-27.17%
Revenue / Employee
$410,233
Profits / Employee
-$709,788
Market Cap
413.37M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 193 | -72 | -27.17% | 188 | 5 |
| Dec 31, 2024 | 265 | -9 | -3.28% | 263 | 2 |
| Dec 31, 2023 | 274 | -43 | -13.56% | 273 | 1 |
| Dec 31, 2022 | 317 | 5 | 1.60% | 317 | 0 |
| Dec 31, 2021 | 312 | 104 | 50.00% | 312 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Autolus Therapeutics | 754 |
| Replimune Group | 479 |
| Lyell Immunopharma | 300 |
| Verastem | 102 |
| Prelude Therapeutics | 79 |
| Century Therapeutics | 78 |
| Larimar Therapeutics | 71 |
| Lexeo Therapeutics | 59 |
ADCT News
- 12 days ago - ADC Therapeutics Earnings Call Transcript: Q1 2026 - Transcripts
- 12 days ago - ADC Therapeutics reports Q1 EPS (13c) vs. (22c) last year - TheFly
- 12 days ago - ADC Therapeutics Reports First Quarter 2026 Financial Results and Provides Operational Updates - PRNewsWire
- 16 days ago - ADC Therapeutics Makes Grants to New Employees Under Inducement Plan - PRNewsWire
- 19 days ago - ADC Therapeutics to Host First Quarter 2026 Financial Results Conference Call on May 4, 2026 - PRNewsWire
- 6 weeks ago - ADC Therapeutics Announces New Employee Inducement Grant - PRNewsWire
- 7 weeks ago - ADC Therapeutics Transcript: H.C. Wainwright Home Series - Transcripts
- 7 weeks ago - ADC Therapeutics price target raised to $8 from $7 at H.C. Wainwright - TheFly